Prospective economic evaluation of a predictive artificial intelligence model for sepsis: Effects on hospital costs and return on investment.
Source check: Source checked. Not independent scientific confirmation.
Finding: The primary paper evaluates deployed BIAlert-Sepsis and associates its implementation with resource-use and cost changes; nonrandomized before–after design precludes causal attribution.
Technology: retrospective quasi-experimental comparison of 6,168 baseline and 1,871 implementation-period sepsis patients, with COVID period excluded; GLM and interrupted time-series/economic analyses. Published abstract reports lower ICU use and costs, but causal attribution is limited by before–after design and mature sepsis program.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- retrospective quasi-experimental comparison of 6,168 baseline and 1,871 implementation-period sepsis patients, with COVID period excluded; GLM and interrupted time-series/economic analyses. Published abstract reports lower ICU use and costs, but causal attribution is limited by before–after design and mature sepsis program.
- Test and result
- retrospective quasi-experimental comparison of 6,168 baseline and 1,871 implementation-period sepsis patients, with COVID period excluded; GLM and interrupted time-series/economic analyses. Published abstract reports lower ICU use and costs, but causal attribution is limited by before–after design and mature sepsis program.
- Limitation / still unknown
- The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0006059
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.